<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Statins for age‐related macular degeneration - Gehlbach, P - 2016 | Cochrane Library</title> <meta content="Statins for age‐related macular degeneration - Gehlbach, P - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006927.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Statins for age‐related macular degeneration - Gehlbach, P - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006927.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006927.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Statins for age‐related macular degeneration" name="citation_title"/> <meta content="Peter Gehlbach" name="citation_author"/> <meta content="Johns Hopkins University School of Medicine" name="citation_author_institution"/> <meta content="pgelbach@jhmi.edu" name="citation_author_email"/> <meta content="Tianjing Li" name="citation_author"/> <meta content="Johns Hopkins Bloomberg School of Public Health" name="citation_author_institution"/> <meta content="Elham Hatef" name="citation_author"/> <meta content="Johns Hopkins Bloomberg School of Public Health (JHBSPH)" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD006927.pub5" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/08/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006927.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006927.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006927.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Hydroxymethylglutaryl‐CoA Reductase Inhibitors [adverse effects, *therapeutic use]; Macular Degeneration [*prevention &amp; control]; Randomized Controlled Trials as Topic; Simvastatin [adverse effects, *therapeutic use]; Visual Acuity" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006927.pub5&amp;doi=10.1002/14651858.CD006927.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="1ljSZou6";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006927\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006927\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","pl","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006927.pub5",title:"Statins for age\\u2010related macular degeneration",firstPublishedDate:"Aug 4, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=1ljSZou6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006927.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006927.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006927.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006927.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006927.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006927.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006927.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006927.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006927.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006927.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2245 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006927.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#CD006927-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#CD006927-sec-0076"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#CD006927-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#CD006927-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#CD006927-sec-0030"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#CD006927-sec-0031"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#CD006927-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#CD006927-sec-0070"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/appendices#CD006927-sec-0080"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Statins for age‐related macular degeneration</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/information#CD006927-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Peter Gehlbach</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/information#CD006927-cr-0003">Tianjing Li</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006927.pub5/information#CD006927-cr-0004">Elham Hatef</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/information/en#CD006927-sec-0092">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 August 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006927.pub5">https://doi.org/10.1002/14651858.CD006927.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006927-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006927-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006927-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006927-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006927-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006927-abs-0001" lang="en"> <section id="CD006927-sec-0001"> <h3 class="title" id="CD006927-sec-0001">Background</h3> <p>Age‐related macular degeneration (AMD) is a progressive, late‐onset disorder of the macula affecting central vision. It is the leading cause of blindness in people over 65 years in industrialized countries. Recent epidemiologic, genetic, and pathological evidence has shown that AMD shares a number of risk factors with atherosclerosis, leading to the hypothesis that statins may exert protective effects in AMD. </p> </section> <section id="CD006927-sec-0002"> <h3 class="title" id="CD006927-sec-0002">Objectives</h3> <p>The objective of this review was to examine the effectiveness of statins compared with other treatments, no treatment, or placebo in delaying the onset and progression of AMD. </p> </section> <section id="CD006927-sec-0003"> <h3 class="title" id="CD006927-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) (2016, Issue 3), Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to March 2016), EMBASE (January 1980 to March 2016), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to March 2016), PubMed (January 1946 to March 2016), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com" target="_blank">www.controlled‐trials.com</a>) (last searched 5 June 2014), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov)" target="_blank">www.clinicaltrials.gov)</a>, and the WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 31 March 2016. </p> </section> <section id="CD006927-sec-0004"> <h3 class="title" id="CD006927-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) and quasi‐randomized trials that compared statins with other treatments, no treatment, or placebo in people who were diagnosed as having the early stages of AMD. </p> </section> <section id="CD006927-sec-0005"> <h3 class="title" id="CD006927-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane. Two review authors independently evaluated the search results against the selection criteria, abstracted data, and assessed risk of bias. We did not perform meta‐analysis due to heterogeneity in the interventions and outcomes between the included studies. </p> </section> <section id="CD006927-sec-0006"> <h3 class="title" id="CD006927-sec-0006">Main results</h3> <p>Two RCTs with a total of 144 participants met the selection criteria. Both trials compared simvastatin versus placebo in older people (older than 50 or 60 years) with high risk of developing AMD (drusen present on examination). Overall, we judged the quality of the evidence to be low, as we downgraded all outcomes due to limitations in the designs of the trials and insufficient outcome reporting. The larger trial, with 114 participants, was conducted in Australia and used a higher dose (40 mg daily) of simvastatin for three years. Participants and study personnel in this trial were adequately masked, however data were missing for 30% of participants at three years' follow‐up. The smaller trial, with 30 participants, was conducted in Italy and used a lower dose (20 mg) of simvastatin for three months. This trial reported insufficient details to assess the risk of bias. </p> <p>Neither trial reported data for change in visual acuity. Low‐quality evidence from the smaller trial, with 30 participants, did not show a statistically significant difference between the simvastatin and placebo groups in visual acuity values at three months of treatment (decimal visual acuity 0.21 ± 0.56 in simvastatin group and 0.19 ± 0.40 in placebo group) or 45 days after the completion of treatment (decimal visual acuity 0.20 ± 0.50 in simvastatin group and 0.19 ± 0.48 in placebo group). The lack of a difference in visual acuity was not explained by lens or retina status, which remained unchanged during and after the treatment period for both groups. </p> <p>Preliminary analyses of 42 participants who had completed 12 months' follow‐up in the larger trial did not show a statistically significant difference between simvastatin and the placebo groups for visual acuity, drusen score, or visual function (effect estimates and confidence intervals were not available). Complete data for these outcomes at three years' follow‐up were not reported. At three years, low‐quality evidence showed an effect of simvastatin in slowing progression of AMD compared with placebo to be uncertain (odds ratio 0.51, 95% confidence interval 0.23 to 1.09). </p> <p>One trial did not report adverse outcomes. The second trial reported no difference between groups in terms of adverse events such as death, muscle aches, and acute hepatitis. </p> </section> <section id="CD006927-sec-0007"> <h3 class="title" id="CD006927-sec-0007">Authors' conclusions</h3> <p>Evidence from currently available RCTs is insufficient to conclude that statins have a role in preventing or delaying the onset or progression of AMD. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006927-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006927-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006927-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006927-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006927-abs-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD006927-abs-0005">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006927-abs-0003">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006927-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006927-abs-0002" lang="en"> <h3>Statins for delaying the onset and progression of age‐related macular degeneration</h3> <p><b>Review question</b> <br/> What are the effects of statins on delaying the onset and progression of age‐related macular degeneration (AMD)? </p> <p><b>Background</b> <br/> AMD is a progressive disease of the macula (area in the back of the eye affecting central vision). AMD is the leading cause of blindness in people over 65 years in industrialized countries. Studies have shown that some of the factors that may lead to heart disease and strokes are the same as those that may lead to AMD. Statins are a type of drug that aims to lower blood cholesterol levels. As statins are very effective in preventing strokes, it is possible that they are also protective for AMD. </p> <p><b>Study characteristics</b> <br/> We included two trials (144 total participants) in this review. Participants included men and women, most of whom were older than 50 years, who had good visual acuity. Participants were either susceptible to or had been diagnosed with an early stage of AMD. Both trials compared simvastatin with placebo. The larger trial, with 114 participants and conducted in Australia, used a higher dose of 40 mg per day and had a treatment period of three years. The smaller trial, with 30 participants and conducted in Italy, used a lower dose of 20 mg per day and had a treatment period of three months. The evidence provided in this review was up‐to‐date as of March 2016. </p> <p><b>Key results</b> <br/> Neither trial provided sufficient evidence to determine whether statins are effective in delaying the onset or progression of AMD. Information was lacking for outcomes related to vision, quality of life, and adverse events. </p> <p><b>Quality of the evidence</b> <br/> The overall quality of the evidence was low. In the smaller trial, the number of participants enrolled and the short treatment period may not have been sufficient for detecting the effect of statins on AMD, which develops over time. In the larger trial, 30% of participants did not attend the three‐year follow‐up visit, and the amount of missing data hindered our ability to draw any reliable conclusions for this trial. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006927-sec-0076" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006927-sec-0076"></div> <h3 class="title" id="CD006927-sec-0077">Implications for practice</h3> <section id="CD006927-sec-0077"> <p>There is insufficient evidence from RCTs to justify the use of statins to delay the onset and progression of AMD or to improve visual acuity. The American Academy of Ophthalmology does not list statins as a treatment option for AMD, which is consistent with the results of the review. </p> </section> <h3 class="title" id="CD006927-sec-0078">Implications for research</h3> <section id="CD006927-sec-0078"> <p>Challenges exist in answering the question of whether statins have beneficial effect in the prevention and treatment of AMD. Due to the slow progressive nature of the disease, trials with a short duration of treatment or follow‐up, or with a small sample size, provide limited information about the effectiveness of statins in the prevention and treatment of AMD. Given that direct treatments for AMD are available (for example anti‐VEGF therapy), and a large proportion of older adults in Western populations are already on statins, it is unlikely that a new RCT would be designed to answer this question specifically. We envision that subsequent data addressing the effectiveness of statins for AMD would come from RCTs evaluating a separate clinical question in which AMD participants are included as a subgroup or AMD is analyzed as a secondary outcome. Future updates of this systematic review may provide conclusive findings that answer this question. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006927-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006927-sec-0022"></div> <div class="table" id="CD006927-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Statins compared with placebo for age‐related macular degeneration</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Statins compared with placebo for age‐related macular degeneration</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> People aged 50 years or older with age‐related macular degeneration </p> <p><b>Settings:</b> Australia and Italy </p> <p><b>Intervention:</b> statins (simvastatin) </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with comparator*</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Risk with intervention</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in visual acuity</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors of <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> did not report visual‐acuity data. Only authors of <a href="https://archie.cochrane.org/sections/documents/view?version=49595521728014574024120205144241%26format=REVMAN#STD-Martini-1991" target="_blank">Martini 1991</a> reported this outcome, showing the decimal visual acuity 0.21 ± 0.56 in simvastatin group and 0.19 ± 0.40 in placebo group at 3 months </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Onset and progression of AMD</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors of <a href="https://archie.cochrane.org/sections/documents/view?version=49595521728014574024120205144241%26format=REVMAN#STD-Martini-1991" target="_blank">Martini 1991</a> did not report data for the onset and progression of AMD. Only authors of <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> reported this outcome, albeit using the last‐observation‐carried‐forward method to account for AMD assessment data for 34 of 144 participants (24%) who missed the 3‐year follow‐up visit. Participants assigned to simvastatin had a lower, but not statistically significant, odds of having AMD progression at 3 years compared with participants in the placebo group (OR 0.51, 95% CI 0.23 to 1.09) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors of <a href="https://archie.cochrane.org/sections/documents/view?version=49595521728014574024120205144241%26format=REVMAN#STD-Martini-1991" target="_blank">Martini 1991</a> did not report adverse events data. Only authors of <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> reported adverse events, which included death, muscle aches, and acute hepatitis. <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> reported that adverse events occurred in 25/57 participants (44%) in the simvastatin group and 39/57 participants (68%) in the placebo group </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*Risk was estimated from the comparator group in the included studies. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AMD:</b> age‐related macular degeneration; <b>CI:</b> confidence interval; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for limitations in the design of available studies suggesting high likelihood of bias (‐1).<br/> <sup>2</sup>Downgraded for poor reporting of outcomes (‐1). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006927-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006927-sec-0023"></div> <section id="CD006927-sec-0024"> <h3 class="title" id="CD006927-sec-0024">Description of the condition</h3> <p>Age‐related macular degeneration (AMD) is a progressive, late‐onset disorder of the macula that affects central vision. Although the leading cause of blindness in people over 65 years in industrialized countries (<a href="./references#CD006927-bbs2-0012" title="CongdonNG , FriedmanDS , LietmanT . Important causes of visual impairment in the world today. JAMA2003;290(15):2057‐60. ">Congdon 2003</a>), its pathogenesis is not clearly understood. It is believed that both genetic and environmental factors play a significant role in the development of the disease. </p> <section id="CD006927-sec-0025"> <h4 class="title">Epidemiology</h4> <p>The prevalence, incidence, and rate of progression of AMD increase with age. The prevalence of any AMD (referred to as age‐related maculopathy) in the Beaver Dam Eye Study was less than 10% in people aged 43 to 54 years, but more than tripled for people aged 75 to 85 years (<a href="./references#CD006927-bbs2-0009" title="American Academy ofOphthalmology . Preferred Practice Pattern Guidelines. Age‐Related Macular Degeneration. www.aao.org/ppp (accessed 7 November 2014). ">AAO 2014</a>; <a href="./references#CD006927-bbs2-0025" title="KleinR , KleinBE , LintonKL . Prevalence of age‐related maculopathy. The Beaver Dam Eye Study. Ophthalmology1992;99(6):933‐43. ">Klein 1992</a>; <a href="./references#CD006927-bbs2-0026" title="KleinR , KleinBE , JensenSC , CruickshanksKJ , LeeKE , DanforthLG , et al. Medication use and the 5‐year incidence of early age‐related maculopathy: The Beaver Dam Eye Study. Archives of Ophthalmology2001;119(9):1354‐9. ">Klein 2001</a>). Joint data from the United States, Netherlands, and Australia indicate the prevalence for late AMD is 0.2% in people 55 to 64 years old, rising sharply to 13% in people over 85 years old (<a href="./references#CD006927-bbs2-0033" title="MitchellP , SmithW , AtteboK , WangJJ . Prevalence of age‐related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology1995;102(10):1450‐60. ">Mitchell 1995</a>; <a href="./references#CD006927-bbs2-0041" title="SmithW , AssinkJ , KleinR , MitchellP , KlaverCC , KleinBE , et al. Risk factors for age‐related macular degeneration: Pooled findings from three continents. Ophthalmology2001;108(4):697‐704. ">Smith 2001</a>). The 10‐year incidence of early AMD and late AMD was 12.1% and 2.1%, respectively in the Beaver Dam Eye Study (<a href="./references#CD006927-bbs2-0027" title="KleinR , KleinBE , TomanySC , MeuerSM , HuangGH . Ten‐year incidence and progression of age‐related maculopathy: The Beaver Dam Eye Study. Ophthalmology2002;109(10):1767‐79. ">Klein 2002</a>). Individuals 75 years of age or older at baseline had significantly higher 10‐year incidences of both early and advanced AMD (<a href="./references#CD006927-bbs2-0027" title="KleinR , KleinBE , TomanySC , MeuerSM , HuangGH . Ten‐year incidence and progression of age‐related maculopathy: The Beaver Dam Eye Study. Ophthalmology2002;109(10):1767‐79. ">Klein 2002</a>). The main risk factors for the development and progression of AMD include increasing age, smoking, and ethnicity. Other reported risk factors include low levels of antioxidants, dietary fat, heart disease, hypertension, genetic influences, alcohol consumption, and sunlight (<a href="./references#CD006927-bbs2-0009" title="American Academy ofOphthalmology . Preferred Practice Pattern Guidelines. Age‐Related Macular Degeneration. www.aao.org/ppp (accessed 7 November 2014). ">AAO 2014</a>). Most of the epidemiologic studies have based their conclusions on few incident cases of advanced AMD. Also, the long intervals between follow‐up examinations or population surveys have meant that some incident cases were likely to have been missed due to deaths, so that the incidence and progression of AMD could not be assessed reliably. </p> </section> <section id="CD006927-sec-0026"> <h4 class="title">Clinical presentation and diagnosis</h4> <p>The early manifestations of AMD are the presence of yellowish deposits known as drusen or retinal pigment epithelium abnormalities such as hypopigmentation or hyperpigmentation observed during retinal examination of eyes. In general, these early clinical signs are not associated with significant vision loss. However, a proportion of people with drusen and pigmentary changes will progress to advanced AMD with geographic atrophy (large area of atrophy centered in the macula) or choroidal revascularization, both of which can have severe effects on central visual function (<a href="./references#CD006927-bbs2-0009" title="American Academy ofOphthalmology . Preferred Practice Pattern Guidelines. Age‐Related Macular Degeneration. www.aao.org/ppp (accessed 7 November 2014). ">AAO 2014</a>; <a href="./references#CD006927-bbs2-0010" title="Age‐Related Eye Disease Study Research Group. A randomized, placebo‐controlled, clinical trial of high‐dose supplementation with vitamins C and E, beta carotene, and zinc for age‐related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology2001;119(10):1417‐36. ">AREDS 2001</a>; <a href="./references#CD006927-bbs2-0011" title="Complications of Age‐Related Macular Degeneration Prevention Trial Study Group. The Complications of Age‐Related Macular Degeneration Prevention Trial (CAPT): rationale, design and methodology. Clinical Trials2004;1(1):91‐107. ">CAPT 2004</a>; <a href="./references#CD006927-bbs2-0039" title="SmeethL , CookC , ChakravarthyU , HubbardR , FletcherAE . A case control study of age related macular degeneration and use of statins. British Journal of Ophthalmology2005;89(9):1171‐5. ">Smeeth 2005</a>). </p> </section> </section> <section id="CD006927-sec-0027"> <h3 class="title" id="CD006927-sec-0027">Description of the intervention</h3> <p>The treatments currently used for neovascular AMD include agents that interfere with vascular endothelial growth factor (VEGF), such as ranibizumab (Lucentis), bevacizumab (Avastin), and aflibercept (Eylea). Administration of these drugs, however, requires multiple intravitreous injections. Although the neovascularization may no longer appear to be 'active', visual recovery or preservation is neither complete nor universal. The risks and benefits of long‐term use are unknown (<a href="./references#CD006927-bbs2-0042" title="SolomonSD , LindsleyK , VedulaSS , KrzystolikMG , HawkinsBS . Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration. Cochrane Database of Systematic Reviews2014, Issue 8. [DOI: 10.1002/14651858.CD005139.pub3] ">Solomon 2014</a>). Photocoagulation and photodynamic therapy were shown to have some benefit in preventing severe visual loss in a small proportion of people with neovascular AMD, and only for a limited time after treatment (<a href="./references#CD006927-bbs2-0034" title="Anonymous . Argon laser photocoagulation for neovascular maculopathy. Five‐year results from randomized clinical trials. Macular Photocoagulation Study Group. Archives of Ophthalmology1991;109(8):1109‐14. ">MPS 1991</a>; <a href="./references#CD006927-bbs2-0035" title="Anonymous . Laser photocoagulation for juxtafoveal choroidal neovascularization. Five‐year results from randomized clinical trials. Macular Photocoagulation Study Group. Archives of Ophthalmology1994;112(4):500‐9. ">MPS 1994</a>; <a href="./references#CD006927-bbs2-0046" title="VirgiliG , BiniA . Laser photocoagulation for neovascular age‐related macular degeneration. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD004763.pub2] ">Virgili 2007</a>; <a href="./references#CD006927-bbs2-0047" title="WormaldR , EvansJ , SmeethL , HenshawK . Photodynamic therapy for neovascular age‐related macular degeneration. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD002030.pub3] ">Wormald 2007</a>). The evidence as to the benefits and harms of surgical injection or implantation of steroids with antiangiogenic properties for treating neovascular AMD is weak (<a href="./references#CD006927-bbs2-0018" title="GeltzerA , TuralbaA , VedulaSS . Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age‐related macular degeneration. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD005022.pub3] ">Geltzer 2013</a>). Antioxidant vitamin and mineral supplements were revealed in the Age‐Related Eye Disease Study (AREDS) to reduce progression to advanced AMD, both the neovascular ('wet') form and the geographic atrophy ('dry') form, in people with intermediate AMD (<a href="./references#CD006927-bbs2-0010" title="Age‐Related Eye Disease Study Research Group. A randomized, placebo‐controlled, clinical trial of high‐dose supplementation with vitamins C and E, beta carotene, and zinc for age‐related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology2001;119(10):1417‐36. ">AREDS 2001</a>). However, aside from the AREDS formulation, there is no proven medical intervention for preventing the onset and progression of this disease (<a href="./references#CD006927-bbs2-0015" title="EvansJR , LawrensonJG . Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD000253.pub3] ">Evans 2012a</a>; <a href="./references#CD006927-bbs2-0016" title="EvansJR , LawrensonJG . Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration. Cochrane Database of Systematic Reviews2012, Issue 11. [DOI: 10.1002/14651858.CD000254.pub3] ">Evans 2012b</a>). </p> </section> <section id="CD006927-sec-0028"> <h3 class="title" id="CD006927-sec-0028">How the intervention might work</h3> <p>The burden of disease would be greatly diminished if a treatment could prevent or delay the onset of early AMD or the progression of early AMD to advanced AMD. Epidemiologic, genetic, and pathological evidence has shown that a number of risk factors are shared by AMD and atherosclerosis, leading to suggestions that statins, which are known to be beneficial in people with atherosclerotic disease and hyperlipidemia, may exert protective effects in AMD. </p> <p>Possible pharmacological mechanisms of statins in preventing AMD include the following (<a href="./references#CD006927-bbs2-0022" title="GuymerRH , ChiuAW , LimL , BairdPN . HMG CoA reductase inhibitors (statins): do they have a role in age‐related macular degeneration?. Survey of Ophthalmology2005;50(2):194‐206. ">Guymer 2005</a>). </p> <p> <ul id="CD006927-list-0001"> <li> <p>Serum lipid‐lowering effects: statins may alter the deposition or resorption characteristics, or both, of lipids in Bruch's membrane (a thin, semi‐permeable cellular structure that acts as the basement membrane for the retinal pigment epithelium and effectively mediates metabolic exchange between the retina and the choroid). </p> </li> </ul> <ul id="CD006927-list-0002"> <li> <p>Preserving vascular supply: statins may preserve vascular supply to the outer retina through a protective effect against atherosclerosis (<a href="./references#CD006927-bbs2-0017" title="FriedmanE . Update of the vascular model of AMD. British Journal of Ophthalmology2004;88(2):161‐3. ">Friedman 2004</a>). </p> </li> </ul> <ul id="CD006927-list-0003"> <li> <p>The anti‐inflammatory actions of statins: inflammation may be important in AMD pathogenesis (<a href="./references#CD006927-bbs2-0036" title="PenfoldPL , MadiganMC , GilliesMC , ProvisJM . Immunological and aetiological aspects of macular degeneration. Progress in Retinal and Eye Research2001;20(3):385‐414. ">Penfold 2001</a>). The anti‐inflammatory properties of statins may provide additional protective effects. Statins down‐regulate the activation of transcription factors NF‐B, AP‐1, and hypoxia‐inducible factor‐1. They therefore have potentially anti‐inflammatory and antiproliferative effects that are relevant in the treatment of atherosclerotic diseases (<a href="./references#CD006927-bbs2-0014" title="DichtlW , DulakJ , FrickM , AlberHF , SchwarzacherSP , AresMPS , et al. HMG‐CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology2003;23(1):58‐63. ">Dichtl 2003</a>). Elevated intraocular levels of vascular endothelial growth factor (VEGF) have an important role in the development of choroidal neovascularization (CNV) in AMD. Prior work indicates that statins reduce plasma levels of VEGF and down‐regulate transcription factors involved in VEGF expression. It is therefore conceivable that systemic statin use may reduce the incidence and progression of CNV via such cellular and molecular effects (<a href="./references#CD006927-bbs2-0014" title="DichtlW , DulakJ , FrickM , AlberHF , SchwarzacherSP , AresMPS , et al. HMG‐CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology2003;23(1):58‐63. ">Dichtl 2003</a>). </p> </li> </ul> <ul id="CD006927-list-0004"> <li> <p>The antioxidant effect of statins: oxidized lipids and low‐density lipoproteins (LDL) may be the initial stimulus leading to inflammation in AMD (<a href="./references#CD006927-bbs2-0020" title="GurneDH , TsoMO , EdwardDP , RippH . Antiretinal antibodies in serum of patients with age‐related macular degeneration. Ophthalmology1991;98(5):602‐7. ">Gurne 1991</a>; <a href="./references#CD006927-bbs2-0043" title="SpaideRF , Ho‐SpaideWC , BrowneRW , ArmstrongD . Characterization of peroxidized lipids in Bruch's membrane. Retina1999;19(2):141‐7. ">Spaide 1999</a>). Statins may protect the outer retina, Bruch's membrane, and choroid from oxidative damage. </p> </li> </ul> <ul id="CD006927-list-0005"> <li> <p>Inhibition of metalloproteinases: statins may also inhibit secretion of matrix metalloproteinases, which may be involved in fissuring and rupture of plaques and development of neovascularization (<a href="./references#CD006927-bbs2-0022" title="GuymerRH , ChiuAW , LimL , BairdPN . HMG CoA reductase inhibitors (statins): do they have a role in age‐related macular degeneration?. Survey of Ophthalmology2005;50(2):194‐206. ">Guymer 2005</a>). </p> </li> </ul> </p> </section> <section id="CD006927-sec-0029"> <h3 class="title" id="CD006927-sec-0029">Why it is important to do this review</h3> <p>The high prevalence of AMD, the anticipated increase in the aged population, and the limited role of available effective treatments highlight the need to search for new treatment strategies for preventing or delaying onset or progression of AMD. A number of observational studies have examined the relationship between AMD and the use of statins; the results have been contradictory. In the Rotterdam Study, those using statins for more than 12 months had a similar incidence of AMD to those not using these drugs (adjusted hazard ratio 1.1, 95% confidence interval (CI) 0.7 to 1.9) (<a href="./references#CD006927-bbs2-0045" title="vanLeeuwenR , VingerlingJR , HofmanA , deJongPT , StrickerBH . Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement. BMJ2003;326(7383):255‐6. ">van Leeuwen 2003</a>). The Beaver Dam Eye Study found the five‐year incidence of neovascular AMD not to be associated with statin use (odds ratio (OR) 0.9, 95% CI 0.46 to 1.78) (<a href="./references#CD006927-bbs2-0026" title="KleinR , KleinBE , JensenSC , CruickshanksKJ , LeeKE , DanforthLG , et al. Medication use and the 5‐year incidence of early age‐related maculopathy: The Beaver Dam Eye Study. Archives of Ophthalmology2001;119(9):1354‐9. ">Klein 2001</a>). A more recent analysis by Klein et al found that a history of statin use was not associated with the five‐year incidence of early AMD (OR 1.16, 95% CI 0.71 to 1.91), progression of AMD (OR 1.16, 95% CI 0.75 to 1.78), or incidence of late AMD (OR 1.27, 95% CI 0.60 to 2.69) (<a href="./references#CD006927-bbs2-0029" title="KleinR , KnudtsonMD , KleinBE . Statin use and the five‐year incidence and progression of age‐related macular degeneration. American Journal of Ophthalmology2007;144(1):1‐6. ">Klein 2007b</a>). The Women's Health Initiative Sight Examination (WHISE), an ancillary study to the Women's Health Initiative's clinical trial of hormone replacement therapy, reported similar negative results (<a href="./references#CD006927-bbs2-0028" title="KleinR , DengY , KleinBE , HymanL , SeddonJ , FrankRN , et al. Cardiovascular disease, its risk factors and treatment, and age‐related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Ophthalmology2007;143(3):473‐83. ">Klein 2007a</a>). One study suggests increased risk with statin use (<a href="./references#CD006927-bbs2-0032" title="McGwinG , ModjarradK , HallTA , XieA , OwsleyC . 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors and the presence of age‐related macular degeneration in the Cardiovascular Health Study. Archives of Ophthalmology2006;124(1):33‐7. ">McGwin 2006</a>). By contrast, animal experiments showed that pitavastatin (so‐called vascular statin) suppressed the formation and development of CNV in rats (<a href="./references#CD006927-bbs2-0038" title="SagaraN , KawajiT , TakanoA , InomataY , InataniM , FukushimaM , et al. Effect of pitavastatin on experimental choroidal neovascularization in rats. Experimental Eye Research2007;84(6):1074‐80. ">Sagara 2007</a>). A strong inverse association between statin use and AMD was reported by Hall et al in a cross‐sectional study with 392 participants (OR 0.14, 95% CI 0.02 to 0.83) and by McGwin et al in a study that involved 550 cases of AMD and 5500 controls (OR 0.3, 95% CI 0.21 to 0.45) (<a href="./references#CD006927-bbs2-0023" title="HallNF , GaleCR , SyddallH , PhillipsDI , MartynCN . Risk of macular degeneration in users of statins: cross sectional study. BMJ2001;323(7309):375‐6. ">Hall 2001</a>; <a href="./references#CD006927-bbs2-0031" title="McGwinGJr , OwsleyC , CurcioCA , CrainRJ . The association between statin use and age related maculopathy. British Journal of Ophthalmology2003;87(9):1121‐5. ">McGwin 2003</a>). Tan et al found that statin use was protective for indistinct soft drusen (hazard ratio 0.33, 95% CI 0.13 to 0.84), a key late AMD precursor lesion, based on their analysis of data from the Blue Mountains Eye Study (<a href="./references#CD006927-bbs2-0044" title="TanJS , MitchellP , RochtchinaE , WangJJ . Statins and the long‐term risk of incident age‐related macular degeneration: The Blue Mountains Eye Study. American Journal of Ophthalmology2007;143(4):685‐7. ">Tan 2007</a>). In a population‐based cohort study, Smeeth et al assessed the effect of statins on a range of health outcomes. A sample of 129,288 people who initiated treatment with a statin were compared with a matched sample of 600,241 people who did not initiate treatment. The hazard ratio of AMD among non‐exposed to exposed study participants was 1.17 (99% CI 1.00 to 1.38), providing no evidence to support a beneficial effect of statin treatment with respect to AMD (<a href="./references#CD006927-bbs2-0040" title="SmeethL , DouglasI , HallAJ , HubbardR , EvansS . Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. British Journal of Clinical Pharmacology2009;67(1):99‐109. ">Smeeth 2009</a>). Observational and animal studies have methodological limitations and may be subject to bias and confounding. A systematic collection and summary of currently available data from high‐quality clinical trials provide the best evidence regarding this issue. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006927-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006927-sec-0030"></div> <p>The objective of this review was to examine the effectiveness of statins compared with other treatments, no treatment, or placebo in delaying the onset and progression of AMD. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006927-sec-0031" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006927-sec-0031"></div> <section id="CD006927-sec-0032"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006927-sec-0033"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs) and quasi‐randomized trials in this review. We considered studies that did not use randomization to allocate participants but utilized techniques intended to allocate participants in an unbiased fashion to be quasi‐randomized trials (for example allocation based on day of the week, year of birth, or hospital admission number of consecutive patients). </p> </section> <section id="CD006927-sec-0034"> <h4 class="title">Types of participants</h4> <p>We included trials that enrolled participants who were diagnosed as having early stages of AMD with no signs of choroidal neovascularization as determined by their study criteria. </p> </section> <section id="CD006927-sec-0035"> <h4 class="title">Types of interventions</h4> <p>We included trials comparing statins, which inhibit the enzyme 3‐hydroxy 3‐methylglutaryl CoA reductase, with other treatments, no treatment, or placebo. We planned to include trials that compared different types of statin therapy, as well as trials in which statins in combination with another treatment were compared with the other treatment alone. </p> </section> <section id="CD006927-sec-0036"> <h4 class="title">Types of outcome measures</h4> <section id="CD006927-sec-0037"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome for comparison of interventions was the change in visual acuity, categorized by loss of three or more lines, no change (within three lines from baseline), and improvement in three or more lines. When continuous LogMAR data were available we analyzed the visual acuity and degree of change as continuous data. The primary time of outcome assessment was at three years' follow‐up, with different follow‐up times analyzed as reported. </p> </section> <section id="CD006927-sec-0038"> <h5 class="title">Secondary outcomes</h5> <p>The secondary outcomes for comparison of interventions were onset and progression of AMD, defined as: </p> <p> <ol id="CD006927-list-0006"> <li> <p>incidence of early signs of AMD using definitions specified in the included studies;</p> </li> <li> <p>incidence of progression from early AMD to intermediate or late stages of AMD using definitions specified in the included studies. </p> </li> </ol> </p> <section id="CD006927-sec-0039"> <h6 class="title">Adverse outcomes</h6> <p>We tabulated all systemic and ocular adverse effects related either to statins or other treatments as reported in the included studies. Specific adverse effects of interest were: </p> <p> <ol id="CD006927-list-0007"> <li> <p>ocular adverse effects;</p> </li> <li> <p>systemic adverse effects.</p> </li> </ol> </p> <section id="CD006927-sec-0040"> <p><b>Economic data</b></p> <p>We planned to document cost‐benefit analyses and other data on economic outcomes in the reported studies. </p> </section> <section id="CD006927-sec-0041"> <p><b>Quality‐of‐life data</b></p> <p>We planned to assess quality‐of‐life data when validated measures were reported.</p> </section> </section> </section> </section> </section> <section id="CD006927-sec-0042"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006927-sec-0043"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) (2016, Issue 3), Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to March 2016), EMBASE (January 1980 to March 2016), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to March 2016), PubMed (January 1946 to March 2016), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com" target="_blank">www.controlled‐trials.com</a>) (last searched 5 June 2014), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov)" target="_blank">www.clinicaltrials.gov)</a>, and the WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 31 March 2016. </p> <p>See: Appendices for details of search strategies for CENTRAL (<a href="./appendices#CD006927-sec-0081">Appendix 1</a>), MEDLINE (<a href="./appendices#CD006927-sec-0082">Appendix 2</a>), EMBASE (<a href="./appendices#CD006927-sec-0083">Appendix 3</a>), LILACS (<a href="./appendices#CD006927-sec-0084">Appendix 4</a>), PubMed (<a href="./appendices#CD006927-sec-0085">Appendix 5</a>), <i>m</i>RCT (<a href="./appendices#CD006927-sec-0086">Appendix 6</a>), ClinicalTrials.gov (<a href="./appendices#CD006927-sec-0087">Appendix 7</a>), and ICTRP (<a href="./appendices#CD006927-sec-0088">Appendix 8</a>). </p> </section> <section id="CD006927-sec-0044"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of the trials included in the review for additional trials. We used the Science Citation Index to find studies that had cited the identified trials. </p> </section> </section> <section id="CD006927-sec-0045"> <h3 class="title" id="CD006927-sec-0045">Data collection and analysis</h3> <section id="CD006927-sec-0046"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently evaluated the titles and abstracts resulting from the electronic and manual searches to identify potentially relevant studies for inclusion. We obtained full copies of all potentially or definitely relevant articles. Two review authors worked independently to determine which studies met the selection criteria. We resolved discrepancies by discussion. We documented the excluded studies and reasons for exclusion in the <a href="./references#CD006927-sec-0099" title="">Characteristics of excluded studies</a> table. </p> </section> <section id="CD006927-sec-0047"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently abstracted data from the included study published in English (<a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a>). Cochrane Eyes and Vision's Italian‐speaking editor (Dr Gianni Virgili) extracted data from the included study published in Italian (<a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a>). This information was verified by a second Italian‐speaking colleague (Dr Fabrizio Giansanti). Study characteristics extracted included: study design, participant characteristics, interventions, and outcomes assessed. One review author entered all data into Review Manager (<a href="./references#CD006927-bbs2-0037" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and a second review author verified the data entered. </p> </section> <section id="CD006927-sec-0048"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors or colleagues (GV and FG) assessed the risk of bias of the included studies according to the methods described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006927-bbs2-0024" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We considered the following parameters: </p> <p> <ol id="CD006927-list-0008"> <li> <p>sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>masking (blinding) of participants, personnel, and outcome assessors;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting;</p> </li> <li> <p>other sources of bias.</p> </li> </ol> </p> <p>We judged each included study to be at low risk of bias, high risk of bias, or unclear risk of bias for each parameter. </p> </section> <section id="CD006927-sec-0049"> <h4 class="title">Measures of treatment effect</h4> <p>We followed guidelines in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006927-bbs2-0013" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>)<i>.</i><a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a> reported the decimal visual acuity (for example 20/20 = 1.0; 20/25 = 0.8, ... 20/200 = 0.10, etc.) and standard deviation by trial group. However, the authors did not report the mean difference between the two treatment arms (P value was mentioned). We could calculate the mean difference in visual acuity based on available data; however, we could not calculate the 95% confidence interval because decimal visual acuity generally does not follow a normal or near‐normal distribution. </p> </section> <section id="CD006927-sec-0050"> <h4 class="title">Dealing with missing data</h4> <p>We contacted authors of RCT reports in an effort to obtain unreported outcome information. We did not impute data for the purposes of this review; however, we used imputed data when reported in the included study reports and documented how missing data were handled. We will update the review when additional data become available. </p> </section> <section id="CD006927-sec-0051"> <h4 class="title">Data synthesis</h4> <p>We did not perform a meta‐analysis as the review included only two trials and each trial reported different outcomes. We will consider meta‐analysis when additional data become available. </p> </section> <section id="CD006927-sec-0052"> <h4 class="title">Sensitivity analysis</h4> <p>We did not perform sensitivity analyses to determine the impact of exclusion of studies with lower methodological quality, exclusion of unpublished studies, or exclusion of industry‐funded studies because no meta‐analysis was conducted. We will perform a sensitivity analysis when data become available from additional clinical trials. </p> <section id="CD006927-sec-0053"> <h5 class="title">'Summary of findings' table</h5> <p>We prepared a 'Summary of findings' table for the following outcomes: mean change in visual acuity, onset and progression of AMD, and adverse outcomes. We used the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) Working Group approach to assess the overall quality of the evidence for each outcome (<a href="./references#CD006927-bbs2-0021" title="GuyattGH , OxmanAD , SchunemannHJ , TugwellP , KnottnerusA . GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology2011;64(4):380‐2. ">Guyatt 2011</a>). We assessed the five major domains of risk of bias, imprecision, inconsistency, publication bias, and indirectness. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006927-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006927-sec-0054"></div> <section id="CD006927-sec-0055"> <h3 class="title">Description of studies</h3> <section id="CD006927-sec-0056"> <h4 class="title">Results of the search</h4> <p>The electronic searches from 30 April 2009 retrieved 97 titles and abstracts, of which five appeared to be relevant (<a href="./references#CD006927-bbs2-0049" title="GehlbachP , LiT , HatefE . Statins for age‐related macular degeneration. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006927.pub2] ">Gehlbach 2009</a>). After examining the full text, we excluded three reports of two studies (<a href="./references#CD006927-bbs2-0004" title="Della ValleV , ScorolliL , MeduriR . Retinal effects of Simvastatin in SMD: Cases up‐date [Effetti retinici della Simvastatina nella DMS: Aggiornamento casistica]. Annali Di Ottalmologia e Clinica Oculistica2000;126(11‐12):249‐55. Della ValleV , ScorolliL , MeduriR . Retinal effects of Simvastatin in patients affected by age related macular degeneration [Effetti retinici della Simvastatina in pazienti affetfi da degenerazione maculare senile correlata all'eta]. Annali Di Ottalmologia e Clinica Oculistica2000;126(5‐6):89‐95. ">Della Valle 2000</a>; <a href="./references#CD006927-bbs2-0008" title="SenK , MisraA , KumarA , PandeyRM . Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Research and Clinical Practice2002;56(1):1‐11. ">Sen 2002</a>), included one study (<a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=AAAB941182E26AA201A04643D0F19502%26versionPK1=49595521728014574024120205144241%26versionPK2=z1412112110272272137945092728118#STD-Martini-1991" target="_blank">Martini 1991</a>), and identified one ongoing study (<a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a>). </p> <p>Updated electronic searches on 16 September 2011 retrieved 35 additional titles and abstracts (<a href="./references#CD006927-bbs2-0050" title="GehlbachP , LiT , HatefE . Statins for age‐related macular degeneration. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD006927.pub3] ">Gehlbach 2012</a>), of which three studies were assessed in full and two studies excluded as they were not RCTs (<a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=AAAB941182E26AA201A04643D0F19502%26versionPK1=49595521728014574024120205144241%26versionPK2=z1412112110272272137945092728118#STD-Drobek_x002d_Slowik-2008" target="_blank">Drobek‐Slowik 2008</a>; <a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=AAAB941182E26AA201A04643D0F19502%26versionPK1=49595521728014574024120205144241%26versionPK2=z1412112110272272137945092728118#STD-Maguire-2009" target="_blank">Maguire 2009</a>). We included another report from the ongoing study first published as an abstract in 2005 (<a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a>). </p> <p>Revised and updated electronic searches on 5 June 2014 yielded 187 new records. We assessed four potentially relevant reports in full, excluding two studies, <a href="./references#CD006927-bbs2-0003" title="BerendschotTT , PlatJ , deJongA , MensinkRP . Long‐term plant stanol and sterol ester‐enriched functional food consumption, serum lutein/zeaxanthin concentration and macular pigment optical density. British Journal of Nutrition2009;101(11):1607‐10. ">Berendschot 2009</a> and <a href="./references#CD006927-bbs2-0007" title="MaoYQ , QiXY , PengW , SunJX , WangAP . Effect of lovastatin on hemodynamic changes in early stage patients with age‐related macular degeneration. International Journal of Ophthalmology2009;9(8):1521‐3. ">Mao 2009</a>, and including two reports from the completed <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> study. Overall, we excluded six studies and included two distinct trials in this review (<a href="./references#CD006927-bbs2-0051" title="GehlbachP , LiT , HatefE . Statins for age‐related macular degeneration. Cochrane Database of Systematic Reviews2015, Issue 2. [DOI: 10.1002/14651858.CD006927.pub4] ">Gehlbach 2015</a>). </p> <p>As of 31 March 2016, the most recent updated electronic searches yielded 39 new records (<a href="#CD006927-fig-0001">Figure 1</a>). None of the new records met our inclusion criteria and all were excluded. </p> <div class="figure" id="CD006927-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006927-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006927.pub5/media/CDSR/CD006927/image_n/nCD006927-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD006927-sec-0057"> <h4 class="title">Included studies</h4> <p>We included two RCTs with a total of 144 participants. The trials included men and women with good baseline visual acuity who were at risk for AMD (presence of drusen). <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> included participants with normal cholesterol levels, whereas <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a> included participants with high cholesterol levels (above 260 mg/dL). <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a>, the larger trial, enrolled 114 participants and was conducted in Australia. <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a>, the smaller trial, enrolled 30 participants and was conducted in Italy. Both trials compared simvastatin with placebo: <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> used a higher dose (40 mg/day) long term (three years), and <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a> used a lower dose (20 mg/day) short term (three months). Although both trials assessed vision‐related outcomes, they used different outcome definitions and time points, precluding pooling of data. Only <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> reported AMD‐related outcomes and adverse events. The primary outcome of <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a> was serum cholesterol level, which was not an outcome assessed in this review. </p> </section> <section id="CD006927-sec-0058"> <h4 class="title">Excluded studies</h4> <p>We excluded six studies because they did not meet our inclusion criteria: four were not RCTs of statin use (<a href="./references#CD006927-bbs2-0003" title="BerendschotTT , PlatJ , deJongA , MensinkRP . Long‐term plant stanol and sterol ester‐enriched functional food consumption, serum lutein/zeaxanthin concentration and macular pigment optical density. British Journal of Nutrition2009;101(11):1607‐10. ">Berendschot 2009</a>; <a href="./references#CD006927-bbs2-0004" title="Della ValleV , ScorolliL , MeduriR . Retinal effects of Simvastatin in SMD: Cases up‐date [Effetti retinici della Simvastatina nella DMS: Aggiornamento casistica]. Annali Di Ottalmologia e Clinica Oculistica2000;126(11‐12):249‐55. Della ValleV , ScorolliL , MeduriR . Retinal effects of Simvastatin in patients affected by age related macular degeneration [Effetti retinici della Simvastatina in pazienti affetfi da degenerazione maculare senile correlata all'eta]. Annali Di Ottalmologia e Clinica Oculistica2000;126(5‐6):89‐95. ">Della Valle 2000</a>; <a href="./references#CD006927-bbs2-0005" title="Drobek‐SlowikM , KarczewiczD , SafranowK , JakubowskaK , ChlubekD . Use of statins as a form of protection against age‐related macular degeneration (AMD) [Leczenie statynami jako forma ochrony przed zwyrodnieniem plamki zwiazanym z wiekiem (AMD)]. Klinika Oczna2008;1‐3:50‐4. ">Drobek‐Slowik 2008</a>; <a href="./references#CD006927-bbs2-0006" title="MaguireMG , YingGS , McCannelCA , LiuC , DaiY , Complications of Age‐related Macular Degeneration Prevention Trial (CAPT) Research Group. Statin use and the incidence of advanced age‐related macular degeneration in the Complications of Age‐related Macular Degeneration Prevention Trial. Ophthalmology2009;116(12):2381‐5. ">Maguire 2009</a>), one enrolled participants with diabetic retinopathy (<a href="./references#CD006927-bbs2-0008" title="SenK , MisraA , KumarA , PandeyRM . Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Research and Clinical Practice2002;56(1):1‐11. ">Sen 2002</a>), and one did not include outcomes relevant to this review (<a href="./references#CD006927-bbs2-0007" title="MaoYQ , QiXY , PengW , SunJX , WangAP . Effect of lovastatin on hemodynamic changes in early stage patients with age‐related macular degeneration. International Journal of Ophthalmology2009;9(8):1521‐3. ">Mao 2009</a>). </p> <p>See: <a href="./references#CD006927-sec-0099" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD006927-sec-0059"> <h3 class="title">Risk of bias in included studies</h3> <p>We have summarized 'Risk of bias' assessments in <a href="#CD006927-fig-0002">Figure 2</a>. We judged <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a> to be at unknown ('unclear') risk of bias on all domains assessed (see <a href="./references#CD006927-sec-0098" title="">Characteristics of included studies</a> table) because insufficient methodological details were reported. </p> <div class="figure" id="CD006927-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006927-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006927.pub5/media/CDSR/CD006927/image_n/nCD006927-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD006927-sec-0060"> <h4 class="title">Allocation</h4> <p>Risk of selection bias was low for <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> and unclear for <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a>. <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> employed a robust method of generating the random sequence by using permuted blocks of randomly varying size and storing the allocation list remotely. </p> <section id="CD006927-sec-0061"> <h5 class="title">Masking (performance bias and detection bias)</h5> <p>We assessed the methods used for masking as adequate for <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> and unclear for <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a>. <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> implemented proper masking of appropriate personnel. Each intervention, simvastatin and placebo, was identically packaged and properly masked limiting performance and detection bias. </p> </section> </section> <section id="CD006927-sec-0062"> <h4 class="title">Incomplete outcome data</h4> <p>Outcome data were missing for more than 25% of participants in <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a>, resulting in a judgement of high risk of attrition bias. The authors of <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> disclosed that 34 out of 114 participants (30%), 20 out of 57 participants (35%) in the simvastatin group, and 14 out of 57 participants (25%) in the placebo group missed the three‐year follow‐up examination. As a result, the authors carried forward the AMD assessment from the last follow‐up visit in their analysis of outcomes. However, use of the last‐observation‐carried‐forward method is not a robust analytic practice in most situations and may not be appropriate when measuring a progressive disease such as AMD (<a href="./references#CD006927-bbs2-0030" title="LiT , HutflessS , ScharfsteinDO , DanielsMJ , HoganJW , LittleRJ , et al. Standards should be applied in the prevention and handling of missing data for patient‐centered outcomes research: a systematic review and expert consensus. Journal of Clinical Epidemiology2013;67(1):15‐32. ">Li 2013</a>). </p> </section> <section id="CD006927-sec-0063"> <h4 class="title">Selective reporting</h4> <p><a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> published results for their primary outcome as stated in their 1998 protocol, and we thus assessed the trial to be at low risk of reporting bias. No protocol for <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a> was available, and we assessed the trial to be at unclear risk of selective outcome reporting. </p> </section> <section id="CD006927-sec-0064"> <h4 class="title">Other potential sources of bias</h4> <p><a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> reported imbalances between the statin and placebo groups with respect to participants with unilateral advanced AMD and smoking at baseline, with the statin group at higher risk of progression to advanced AMD. </p> </section> </section> <section id="CD006927-sec-0065"> <h3 class="title" id="CD006927-sec-0065">Effects of interventions</h3> <p>See: <a href="./full#CD006927-tbl-0001"><b>Summary of findings for the main comparison</b> Statins compared with placebo for age‐related macular degeneration</a> </p> <p>Due to heterogeneity in outcome measures and time points between trials, we did not combine the trial results in a meta‐analysis. The overall quality of the evidence was low for all review outcomes (<a href="./full#CD006927-tbl-0001">summary of findings Table for the main comparison</a>); we downgraded for limitations in the designs of the available studies suggesting high likelihood of bias (‐1) and lack of reported outcomes suggesting high probability of publication bias (‐1). </p> <section id="CD006927-sec-0066"> <h4 class="title">Change in visual acuity</h4> <p>Neither trial reported change in visual acuity at three years' follow‐up, the primary outcome and time point for this review. Although visual‐acuity data were not reported at three years in <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a>, possibly because progression of AMD was their primary outcome and not visual acuity, data were reported in preliminary 12‐month results. Analyses of 42 participants (19 in the simvastatin arm and 23 in the placebo arm) who completed 12 months' follow‐up showed no statistically significant difference between the two groups in visual acuity, drusen score, or visual function (effect estimates and confidence intervals (CIs) were not available). We contacted the trial investigators and will update the review as data become available. </p> <p>In <a href="https://archie.cochrane.org/sections/documents/view?version=49595521728014574024120205144241%26format=REVMAN#STD-Martini-1991" target="_blank">Martini 1991</a>, analysis of 30 participants after three months of treatment showed similar results between the simvastatin and placebo groups in terms of visual acuity (decimal visual acuity 0.21 ± 0.56 in the simvastatin group and 0.19 ± 0.40 in the placebo group). The authors did not report values for mean changes in visual acuity. Visual acuity results were also similar at 45 days after the completion of the treatment period (decimal visual acuity 0.20 ± 0.50 in the simvastatin group and 0.19 ± 0.48 in the placebo group). </p> </section> <section id="CD006927-sec-0067"> <h4 class="title">Onset and progression of AMD</h4> <p><a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> used the last‐observation‐carried‐forward method to account for AMD assessment data for 34 of 144 participants (24%) who missed the three‐year follow‐up visit. Participants assigned to simvastatin had lower, but not statistically significant, odds of having AMD progression at three years compared with participants in the placebo group (odds ratio (OR) 0.51, 95% CI 0.23 to 1.09). <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a> did not report onset or progression of AMD but reported that the lens and retina status were unchanged during and after the treatment period for both groups. </p> </section> <section id="CD006927-sec-0068"> <h4 class="title">Adverse outcomes</h4> <p><a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> reported that adverse events occurred in 25 out of 57 participants (44%) in the simvastatin group and 39 out of 57 participants (68%) in the placebo group. Reported adverse events included death, muscle aches, and acute hepatitis. Participants did not have abnormal liver function. <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a> did not report adverse events. </p> </section> <section id="CD006927-sec-0069"> <h4 class="title">Economic and quality‐of‐life outcomes</h4> <p>Neither study reported economic or quality‐of‐life outcomes.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006927-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006927-sec-0070"></div> <section id="CD006927-sec-0071"> <h3 class="title" id="CD006927-sec-0071">Summary of main results</h3> <p>We identified two RCTs, with a total of 144 participants, comparing simvastatin with placebo. We did not perform meta‐analysis due to the heterogeneity between the trials: <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> used a higher dose (40 mg/day) of simvastatin over a longer time period (three years), and <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a> used a lower dose (20 mg/day) of simvastatin over a shorter time period (three months). This review did not find sufficient evidence to determine the effectiveness and safety of statins to prevent or delay the progression of AMD. </p> </section> <section id="CD006927-sec-0072"> <h3 class="title" id="CD006927-sec-0072">Overall completeness and applicability of evidence</h3> <p>One trial, <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a>, had a small sample size of 30 participants at an early stage of disease. The other trial, <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a>, had a larger sample size of 114 participants, but 30% of participants missed the three‐year follow‐up. The evidence appears to be incomplete given that slightly less than one‐third of the participants did not complete the last follow‐up visit in the largest trial. The two included trials were limited to simvastatin. It is unknown whether other statins have similar or different effects. Since the studies included participants with early AMD, this evidence is applicable to people at an earlier stage of the disease; the applicability of these findings to those with advanced AMD is unknown. The primary outcomes differed between the two studies, and neither trial reported change in visual acuity at three years' follow‐up as an outcome. The trials were conducted in Italy and Australia, and the applicability of this evidence to other settings, such as the US and low‐ to ‐middle‐income countries, is unknown. Limited information was available on whether findings were different across age and gender categories. </p> </section> <section id="CD006927-sec-0073"> <h3 class="title" id="CD006927-sec-0073">Quality of the evidence</h3> <p><a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a> assessed visual acuity at the completion of treatment (three months from baseline) and 45 days afterwards. Due to the slow, progressive nature of the disease, the short duration of treatment and follow‐up may not provide useful information about the effectiveness of treatment because it may be too short to show an effect. In addition, we judged the trial as unclear for all risk of bias domains because of insufficient reporting of methodological details. Although no ophthalmological adverse effects were reported during the study period, there was still a degree of uncertainty about the accuracy of this finding because of the short follow‐up period. </p> <p><a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> assessed progression and onset of AMD at three‐year follow‐up. However, the level of missing data was about 30% and the trial investigators used the last‐observation‐carried‐forward method to account for the missing data. This method of dealing with missing data is not robust and may not be appropriate in assessing outcomes for progressive diseases, thus making the conclusions unreliable. </p> </section> <section id="CD006927-sec-0074"> <h3 class="title" id="CD006927-sec-0074">Potential biases in the review process</h3> <p>We followed standard methodological procedures recommended by Cochrane in order to minimize potential biases in the review process. </p> <p>The absence of evidence on harms in the <a href="./references#CD006927-bbs2-0002" title="MartiniE , ScorolliL , BurgagniMS , FessehaieS . Evaluation of the retinal effects of simvastatin in patients with age‐related macular degeneration [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica1991;117(11):1121‐6. ">Martini 1991</a> trial may relate to the short duration of follow‐up and inadequate power of the trial to detect meaningful differences in important but infrequent events between treatment groups. The long‐term treatment and follow‐up of the participants in the larger <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> trial provide more information about the effectiveness of treatment and the potential harms; however, caution is needed in interpreting these results as data were missing for a substantial proportion of participants. </p> </section> <section id="CD006927-sec-0075"> <h3 class="title" id="CD006927-sec-0075">Agreements and disagreements with other studies or reviews</h3> <p>The American Academy of Ophthalmology does not list statins as a treatment option for AMD, which is consistent with our finding of inadequate evidence to support the use of statins to slow progression of early AMD. We also found little or no evidence that statins improve visual‐acuity outcomes in AMD. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006927-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/media/CDSR/CD006927/urn:x-wiley:14651858:media:CD006927:CD006927-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/media/CDSR/CD006927/image_t/tCD006927-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006927-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006927.pub5/media/CDSR/CD006927/image_n/nCD006927-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#CD006927-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/media/CDSR/CD006927/image_n/nCD006927-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006927-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/media/CDSR/CD006927/urn:x-wiley:14651858:media:CD006927:CD006927-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/media/CDSR/CD006927/image_t/tCD006927-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006927-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006927.pub5/media/CDSR/CD006927/image_n/nCD006927-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#CD006927-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/media/CDSR/CD006927/image_n/nCD006927-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006927-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Statins compared with placebo for age‐related macular degeneration</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Statins compared with placebo for age‐related macular degeneration</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> People aged 50 years or older with age‐related macular degeneration </p> <p><b>Settings:</b> Australia and Italy </p> <p><b>Intervention:</b> statins (simvastatin) </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with comparator*</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Risk with intervention</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in visual acuity</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors of <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> did not report visual‐acuity data. Only authors of <a href="https://archie.cochrane.org/sections/documents/view?version=49595521728014574024120205144241%26format=REVMAN#STD-Martini-1991" target="_blank">Martini 1991</a> reported this outcome, showing the decimal visual acuity 0.21 ± 0.56 in simvastatin group and 0.19 ± 0.40 in placebo group at 3 months </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Onset and progression of AMD</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors of <a href="https://archie.cochrane.org/sections/documents/view?version=49595521728014574024120205144241%26format=REVMAN#STD-Martini-1991" target="_blank">Martini 1991</a> did not report data for the onset and progression of AMD. Only authors of <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> reported this outcome, albeit using the last‐observation‐carried‐forward method to account for AMD assessment data for 34 of 144 participants (24%) who missed the 3‐year follow‐up visit. Participants assigned to simvastatin had a lower, but not statistically significant, odds of having AMD progression at 3 years compared with participants in the placebo group (OR 0.51, 95% CI 0.23 to 1.09) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors of <a href="https://archie.cochrane.org/sections/documents/view?version=49595521728014574024120205144241%26format=REVMAN#STD-Martini-1991" target="_blank">Martini 1991</a> did not report adverse events data. Only authors of <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> reported adverse events, which included death, muscle aches, and acute hepatitis. <a href="./references#CD006927-bbs2-0001" title="GuymerRH , BairdPN , VarsamidisM , BusijaL , DimitrovPN , AungKZ , et al. Proof of concept, randomized, placebo‐controlled study of the effect of simvastatin on the course of age‐related macular degeneration. PLoS One2013;8(12):e83759. GuymerRH , ChiuA , RobmanL , O'LoughlinRK , TikellisG , DimitrovP , et al. Slowing progression of age‐related macular degeneration with statins: a randomised, controlled clinical trial. Investigative Ophthalmology and Visual Science2003;44:ARVO E‐abstract 1807. GuymerRH , DimitrovPN , VarsamidisM , LimLL , BairdPN , VingrysAJ , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of age‐related macular degeneration? The age‐related maculopathy statin study (ARMSS). Clinical Interventions in Aging2008;3(3):581‐93. GuymerRH , RobmanL , VarsamidisM , DimitrovP , HuntN , LimL , et al. Can HMG Co‐A reductase inhibitors (&quot;statins&quot;) slow the progression of AMD?. Investigative Ophthalmology and Visual Sciences2005; Vol. 46:ARVO E‐abstract 2364. ">Guymer 2013</a> reported that adverse events occurred in 25/57 participants (44%) in the simvastatin group and 39/57 participants (68%) in the placebo group </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*Risk was estimated from the comparator group in the included studies. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AMD:</b> age‐related macular degeneration; <b>CI:</b> confidence interval; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for limitations in the design of available studies suggesting high likelihood of bias (‐1).<br/> <sup>2</sup>Downgraded for poor reporting of outcomes (‐1). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Statins compared with placebo for age‐related macular degeneration</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006927.pub5/full#CD006927-tbl-0001">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006927.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006927-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006927-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD006927-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD006927-note-0003">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD006927-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006927-note-0009">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006927\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006927\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006927\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006927\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006927\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=1ljSZou6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006927.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006927.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006927.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006927.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006927.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728556644"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006927.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728556647"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006927.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ec75dcebbf431',t:'MTc0MDcyODU1Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 